In this large retrospective cohort study, data from >750 patients with EGFR mutation-positive NSCLC, obtained from a shared hospital electronic medical record system covering the period from 2010 to 2020, showed no significant difference in OS between non-recipients and recipients of public assistance or residents of megalopolis and other regions. This evidence concerns the gene EGFR and non-small cell lung carcinoma.